Article Menu
Need Help?
No Article Versions Notes Found
Cite
Srikanthan, A.; Mai, H.; Penner, N.; Amir, E.; Laupacis, A.; Sabharwal, M.; Chan, K.K.W. Impact of the Pan-Canadian Oncology Drug Review on Provincial Concordance with Respect to Cancer Drug Funding Decisions and Time to Funding. Curr. Oncol. 2017, 24, 295-301. https://doi.org/10.3747/co.24.3648
Srikanthan A, Mai H, Penner N, Amir E, Laupacis A, Sabharwal M, Chan KKW. Impact of the Pan-Canadian Oncology Drug Review on Provincial Concordance with Respect to Cancer Drug Funding Decisions and Time to Funding. Current Oncology. 2017; 24(5):295-301. https://doi.org/10.3747/co.24.3648
Chicago/Turabian StyleSrikanthan, A., H. Mai, N. Penner, E. Amir, A. Laupacis, M. Sabharwal, and K. K. W. Chan. 2017. "Impact of the Pan-Canadian Oncology Drug Review on Provincial Concordance with Respect to Cancer Drug Funding Decisions and Time to Funding" Current Oncology 24, no. 5: 295-301. https://doi.org/10.3747/co.24.3648
APA StyleSrikanthan, A., Mai, H., Penner, N., Amir, E., Laupacis, A., Sabharwal, M., & Chan, K. K. W. (2017). Impact of the Pan-Canadian Oncology Drug Review on Provincial Concordance with Respect to Cancer Drug Funding Decisions and Time to Funding. Current Oncology, 24(5), 295-301. https://doi.org/10.3747/co.24.3648
